
TAK
Healthcare · Drug Manufacturers - Specialty & Generic · $68.47B market cap
$21.43+0.31 (+1.5%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | Before the open | 0.31 | 0.51 | +64.5% |
| Jul 30, 2026 | Before the open | 0.41 | 0.48 | +17.1% |
| May 14, 2026 | Time not confirmed | — | -0.74 | — |
| Jan 29, 2026 | Before the open | — | 0.21 | — |
| Oct 30, 2025 | Before the open | 0.15 | -0.03 | -116.8% |
| Jul 30, 2025 | Before the open | 0.20 | 151.00 | +75174.2% |
| May 8, 2025 | Time not confirmed | -0.17 | -0.23 | -37.1% |
| Jan 30, 2025 | Before the open | 0.63 | 0.05 | -92.4% |
| Oct 31, 2024 | Before the open | 87.45 | 29.07 | -66.8% |
| Jul 31, 2024 | Before the open | 0.12 | 0.19 | +56.6% |
| May 9, 2024 | Before the open | -0.01 | -0.01 | +54.2% |
| Feb 1, 2024 | Before the open | 0.11 | 33.79 | +31042.9% |
| Oct 26, 2023 | Before the open | 0.14 | -15.50 |
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase,…
| -10856.4% |
| Jul 27, 2023 | Before the open | 18.62 | 28.76 | +54.5% |
| May 22, 2023 | After the close | 0.05 | 0.07 | +46.5% |
| Feb 2, 2023 | Time not confirmed | 0.29 | 0.29 | +0.9% |
| Oct 27, 2022 | Before the open | 67.54 | 20.03 | -70.3% |
| Jul 28, 2022 | Before the open | 59.27 | 33.97 | -42.7% |
| May 11, 2022 | Before the open | 0.06 | -0.03 | -144.7% |
| Feb 3, 2022 | Before the open | 0.22 | 0.16 | -27.2% |
| Oct 28, 2021 | Before the open | 97.00 | -5.13 | -105.3% |
| Jul 30, 2021 | Before the open | 95.00 | 64.00 | -32.6% |
| May 11, 2021 | Before the open | 88.00 | 63.08 | -28.3% |
| Feb 4, 2021 | Before the open | 105.00 | 29.78 | -71.6% |
| Oct 29, 2020 | Before the open | 103.00 | 1.38 | -98.7% |
| Jul 31, 2020 | Before the open | 85.00 | 26.35 | -69.0% |
| May 13, 2020 | Before the open | -0.21 | 0.55 | +361.9% |
| Feb 4, 2020 | Before the open | 75.00 | 3.00 | -96.0% |
| Nov 13, 2019 | After the close | -0.21 | 0.16 | +176.2% |
| Jul 31, 2019 | Before the open | -0.19 | -0.06 | +67.7% |
| May 14, 2019 | Before the open | -0.36 | -0.62 | -72.2% |
| Feb 1, 2019 | Before the open | 0.10 | 0.22 | +118.6% |
| Oct 31, 2018 | Before the open | 0.23 | 0.27 | +19.0% |
| Jul 31, 2018 | Before the open | 0.31 | 0.45 | +44.1% |
| May 14, 2018 | Before the open | -0.37 | -0.31 | +15.1% |
| Feb 1, 2018 | Time not confirmed | — | 0.40 | — |